The Discounted Cash Flow (DCF) valuation of Emergent BioSolutions Inc (EBS) is (0.53) USD. With the latest stock price at 7.33 USD, the upside of Emergent BioSolutions Inc based on DCF is -107.3%.
Based on the latest price of 7.33 USD and our DCF valuation, Emergent BioSolutions Inc (EBS) is a sell. selling EBS stocks now will result in a potential gain of 107.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 15.6% | 10.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (3.75) - 86.32 | (0.53) |
| Upside | -151.1% - 1077.7% | -107.3% |